Showing results (1711-1720 of 1,831) with videos related to

Sort By:
Pageof 184
Vascular Pharmacology|July 27, 2025
Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?Ashot Avagimyan, Rosalinda Madonna, Mohammad Sheibani, et al.
Circulation|November 20, 2013
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgeryDomenico D'Amario, Antonio M Leone, Antonio Iaconelli, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 22, 2017
p140Cap Regulates GABAergic Synaptogenesis and Development of Hippocampal Inhibitory CircuitsIsabella Russo, Daniela Gavello, Elisabetta Menna, et al.
Chest|December 15, 2024
Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter StudyMaria Otaola, Eirini Vasarmidi, Sébastien Ottaviani, et al.
Rheumatology (Oxford, England)|December 14, 2024
Development and internal-external cross-validation of a patient-reported definition for acute calcium pyrophosphate crystal arthritisEdoardo Cipolletta, Davide Rozza, Mariano Andres, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2023
MicroRNA-216a is essential for cardiac angiogenesisRio P Juni, Jordy M M Kocken, Ricardo C Abreu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 6, 2022
TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective StudyMarco Percetti, Giulia Franco, Edoardo Monfrini, et al.
American Journal of Human Genetics|February 1, 2025
Inter-chromosomal insertions at Xq27.1 associated with retinal dystrophy induce dysregulation of LINC00632 and CDR1as/ciRS-7Jessica C Gardner, Katarina Jovanovic, Daniele Ottaviani, et al.
Leukemia Research|January 1, 2021
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patientsGiovanni Marconi, Stefano De Polo, Giovanni Martinelli, et al.
Blood|February 15, 2007
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJelena V Jovanovic, Joannah Score, Katherine Waghorn, et al.
Pageof 184